This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing the efficacy of Bavarian Nordic's vaccine and the overall concern for Monkeypox outbreak: A first look at the concerns and treatment needs of monkeypox
Ticker(s): BVNRYWho's the expert?
Institution: Johns Hopkins
- Senior Scholar at the Johns Hopkins University Center for Health Security.
- Served on US government panels tasked with developing guidelines for the treatment of plague, botulism, and anthrax in mass casualty settings and the system of care for infectious disease emergencies.
- Formerly a member of the National Quality Forum’s Infectious Disease Standing Committee and the US Department of Health and Human Services’ National Disaster Medical System.
Interview GoalDiscuss the level of concern and treatment need for this new outbreak. Also, discuss efficacy of Bavarian Nordic's monkeypox vaccine.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
